MK6349

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK6349, covering 2015-08-27 to 2015-08-27. Get the full timeline:

Most recent: Clinical Trial Update: A Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002) [Phase 1]